# PILL holdings: all 66 positions

> PILL holdings as of Oct 22, 2026: swaps on SPSIPH worth 230.8% of net assets, and the cash behind them. Every line, with its source and date.

Data as of Oct 22, 2026. Rebuilt every trading night.

PILL held swaps on SPSIPH worth 230.8% of its net assets on Oct 22, 2026. With the 69.2% it holds directly, its exposure is 300.0%.

Source: Direxion (<https://www.direxion.com/product/daily-pharmaceutical-medical-bull-3x-etf>).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | SPSIPH swap asset leg | SPSIPH | 109.65% |
| 2 | SPSIPH swap asset leg | SPSIPH | 56.97% |
| 3 | SPSIPH swap asset leg | SPSIPH | 54.83% |
| 4 | SPSIPH swap asset leg | SPSIPH | 9.32% |
| 5 | Xeris Biopharma Holdings Inc |  | 1.96% |
| 6 | Veradermics Inc |  | 1.94% |
| 7 | Pacira Biosciences Inc |  | 1.76% |
| 8 | Amneal Pharmaceuticals Inc |  | 1.65% |
| 9 | ELI Lilly & Co |  | 1.61% |
| 10 | Maze Therapeutics Inc |  | 1.61% |
| 11 | Perrigo Co PLC |  | 1.59% |
| 12 | Viatris Inc |  | 1.56% |
| 13 | Zoetis Inc |  | 1.56% |
| 14 | Pfizer Inc |  | 1.52% |
| 15 | Ligand Pharmaceuticals |  | 1.49% |
| 16 | Royalty Pharma PLC- Cl A |  | 1.47% |
| 17 | ANI Pharmaceuticals Inc |  | 1.45% |
| 18 | Indivior Pharmaceuticals Inc |  | 1.42% |
| 19 | Prestige Consumer Healthcare |  | 1.42% |
| 20 | Septerna Inc |  | 1.40% |
| 21 | Organon & Co |  | 1.40% |
| 22 | Johnson & Johnson |  | 1.39% |
| 23 | Supernus Pharmaceuticals Inc |  | 1.39% |
| 24 | Merck & Co. Inc. |  | 1.39% |
| 25 | Innoviva Inc |  | 1.39% |
| | Goldman Finl Sq Trsry Inst 506 | | 19.24% |
| | Dreyfus Govt Cash Man Ins | | 5.64% |
| | Goldman Sachs Fin Gov 465 Institut | | 5.13% |

The largest 25 of 66 positions are shown. All of them: https://etfiq.com/funds/pill/holdings/pill-holdings.csv (CSV) or https://etfiq.com/funds/pill/holdings/index.json (JSON).

Fund page: https://etfiq.com/funds/pill

Cite: ETFIQ, Holdings of PILL, data as of Oct 22, 2026. https://etfiq.com/funds/pill/holdings/